Author of the article: Pembroke Observer and News
Publishing date: Dec 17, 2020 • December 31, 2020 • 1 minute read •
Article content
On Dec. 11, at approximately 11:30 a.m., members of the Upper Ottawa Valley (UOV) Ontario Provincial Police (OPP) Community Street Crime Unit (CSCU) arrested a wanted individual in a parked vehicle near the intersection of Mary and Murray Streets in the City of Pembroke.
As a result of the arrest police located and seized a quantity of drugs, cellphones, cash and drug paraphernalia. A second occupant of the vehicle was also charged with drug offences.
We apologize, but this video has failed to load.
Try refreshing your browser.
Handguns, cocaine seized in Wasaga Beach bust
Four people have been charged, including two Wasaga residents, a Markham man, and a youth
Dec 15, 2020 3:57 PM By: BarrieToday Staff
WASAGA BEACH - On Dec. 10, 2020, members of the Huronia West OPP Community Street Crime Unit (CSCU) with the assistance of the Emergency Response Team (ERT) executed a search warrant at a residence in Wasaga Beach.
Officers seized two handguns from inside the residence, one of which was loaded. A conducted energy weapon (commonly referred to as a Taser ) and a set of brass knuckles were also seized along with 100 grams of suspected cocaine and drug trafficking materials.
In other industry news of note:
Mydecine Innovations Group (CSE:MYCO) (MYCO.CNQ), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, recently announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. As part of the agreement, ProPharma Group will provide regulatory advisement as the company seeks approval from the Food and Drug Administration (FDA) for its drug development platform as well as the Company s various stage clinical trials. ProPharma Group is a globally recognized firm with a strong track record of working with life sciences and biopharma companies to ensure full compliance with all FDA regulations, including all necessary steps for eventual global federal approvals, said Josh Bartch, CEO and Co-Founder of Mydecine. Mydecine cur
Share:
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE)
Pure Extracts Technologies Corp. (CSE:PULL) (XFRA: A2QJAJ) ( Pure Extracts or the Company ), a plant-based extraction company, is pleased to announce that it has begun to build-out the 4
th unit in its facility for the extraction of mushrooms and to commence research and development of psilocybin under a Dealer s Licence.
The Company is preparing an application to Health Canada for a Dealer s Licence under the Controlled Drugs and Substances Act (CDSA), which provides, among other things, the framework for legal access to controlled substances, and the control and regulation of production, distribution and sale of psilocybin.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
REPEAT - Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion
Pure Extracts Technologies Corp.December 15, 2020 GMT Special Access Programme Review Considered a Milestone Event Toward Mainstream Acceptance
VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, and the rapidly emerging functional mushroom sector, is pleased to support Health Canada’s proposed intent to revise the Special Access Programme (SAP) and related regulations to permit certain authorized uses of psilocybin-assisted psychotherapeutic treatments. The intended SAP revision, announced on December 11th, could lead to important new medical applications, particularly in the complex and growing mental health secto